Table 1.
Demographic and clinical characteristics of patients with schizophrenia and of control subjects.
| Patients (N = 35) | Control subjects (N = 20) | |
|---|---|---|
| Mean ± SD | Mean ± SD | |
| Demographic characteristics | ||
| Age (years) | 31.2 ± 10.3 | 31.7 ± 9.6 |
| Gender (male:female) | 24:11 | 13:7 |
| Education (years) | 13.4 ± 2.5 | 16.9 ± 1.8 |
| Moberg pick-up test (functional dexterity measure) | 16.8 ± 7.6 s | 12.0 ± 2.2 s |
| Clinical characteristics | ||
| Age at first episode (years) | 21.2 ± 6.4 | |
| Disease duration (years) | 12.1 ± 9.1 | |
| Age of first antipsychotic treatment (years) | 21.4 ± 5.3 | |
| Age of first hospitalization (years) | 23.6 ± 6.8 | |
| Number of hospitalizations | 3.0 ± 2.5 | |
| Simpson-Angus Extrapyramidal scale | 1.05 ± 2.06 | |
| Antipsychotic treatment | ||
| Chlorpromazine equivalent (CPZe, mg/day) | 431± 340 | |
| Other pharmacological treatments | % of Patients | |
| Antidepressant | 34 | |
| Anxiolytic | 26 | |
| Anticholinergic | 11 | |
| Hypnotic/sedative | 9 | |
| Thymoregulator | 6 | |